Tempong, Andresto A.
HRN: 28-45-51 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2026
04/13/2026
IV
500mg
Q8
Infectious Diarrhea
Checking Initial Appropriateness
04/06/2026
CIPROFLOXACIN 500MG (TAB)
04/06/2026
04/12/2026
ORAL
500mg
BID
Amoebiasis
Checking Initial Appropriateness
04/08/2026
METRONIDAZOLE 500MG (TAB)
04/08/2026
04/14/2026
PO
500mgtab
TID
Amoebiasis
Checking Initial Appropriateness